References
1. Чазова И.Е., Мартынюк Т.В. Легочная гипертензия. М.: Практика; 2015: 325.
2. Von Romberg E. Ueber Sklerose der Lungen arterie. Dsch Archiv Klin. Med. 1891; 48: 197-206.
3. Ivy D.D. et al. Proceedings of the 5th World Symposium on Pulmonary Hypertension. Pediatric Pulmonary Hypertension. J. Am. Coll. Cardiol. 2013; 62: 117-26.
4. Simonneau G, Gatzoulis M.A., Adatia I. et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62: 34-41.
5. Чазов Е.И. Клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиологический журнал. 2014; 4: 5-24.
6. Galie N., Hoeper M.M., Humbert M. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology and the European Respiratory Society, endorsed by the International Society of Heart and Lung Transplantation. Eur. Heart J. 2009; 30: 2493-537.
7. Беленков ЮН., Чазова И.Е. Первичная легочная гипертензия. М.: Нолидж; 1991.
8. Humbert M., Sitbon O., Chaouat A. et al. Pulmonary arterial hypertension in France: results from a national registry. Am. J. Respir. Crit. Care. Med. 2006; 173: 1023-30.
9. D’Alonzo G.E., Barst R.J, Ayres S.M. et al. Survival in patients with primary pulmonary hypertension. Ann. Int. Med. 1991; 115: 343-9.
10. Rozkovec A, Montanes P, Oakley C.M. Factors that influence the outcome of primary pulmonary hypertension. Br. Heart J. 1986; 55(5): 449-58.
11. Young D., Mark H. Fate of the patient with the Eisenmenger syndrome. Am. J. Cardiol. 1971; 28(6): 658-69.
12. Hopkins W.E., Ochoa L.L., Richardson G.W., Trulock E.P. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J. Heart Lung Transplant. 1996; 15: 100-5.
13. Sajan I., Manlhiot C., Reyes J. et al. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. Am. Heart J. 2011; 162 (3): 562-8.
14. Devika Sennik. Idiopathic pulmonary arterial hypertension: a national cohort study. Heart. 2010; 96: 1401-6.
15. Бокерия Л.А., Горбачевский С.В., Школьникова М.А. Руководство по легочной гипертензии у детей. М.: Актелион Фармасьютикалз; 2013: 63-4.
16. McLaughlin V.V., Archer S., Badesch D.B. et al. ACCF/AHA 2009 Expert Consensus Document on pulmonary hypertension: A report of the American College of Cardiology Foundation task force of export consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society and the Pulmonary Hypertension Association. J. Am. Coll. Cardiol. 2009; 53; 1573-619.
17. Gibbs J.S. Consensus statement on the management of the pulmonary hypertension in clinical practice in the UK and Ireland. Thorax. 2008; 63: 1-41.
18. Rich S., Kaufman E., Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N. Engl. J. Med. 1992; 237: 76-81.
19. Sitbon O., Humbert M., Jais X., Loos V., Hamid A.M., Provencher S. et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005; 111: 3105-11.
20. Barst R.J. Pharmacological induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. Chest. 1986; 89: 497-503.
21. Алекян Б.Г., Пурсанов М.Г. Стентирование межпредсердной перегородки. В кн.: Бокерия Л.А., Алекян Б.Г. (ред.). Руководство по рентгенэндоваскулярной хирургии сердца и сосудов. М.: НЦССХ им. А.Н. Бакулева РАМН; 2008; 2: 57-65.
22. Gorbachevsky S.V., Belkina M.V., Pursanov M.G., Tkacheva A.V., Vladimirskaya M. A., Koroleva N.I., Alekyan B.G. Atrial septostomy as a long bridge to lung transplantation in patients with idiopathic pulmonary arterial hypertension. J. Cardiovasc. Surg. 2012; 53 (2): 11.
23. Алекян Б.Г, Пурсанов М.Г., Горбачевский С.В., Рзаев Ф.Г., Гренадеров М.А., Дадабаев Г.М. и др. Стентирование межпредсердной перегородки у пациентов с идиопатической легочной артериальной гипертензией. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2015; 16 (6, Прил.): 22.
24. Potts W.J., Smith S., Gibson S. Anastomosis of the aorta to a pulmonary artery; certain types in congenital heart disease. J. Am. Med. Assoc. 1946; 132: 627-31.
25. Blanc J., Vouhe P, Bonnet D. Potts shunt in patients with pulmonary hypertension. N. Engl. J. Med. 2004; 350: 623.
26. Baruteau A.E., Serraf A., Levy M., Bonnet D., Jais X, Vouhe P. et al. Potts shunt in children with idiopathic pulmonary arterial hypertension: long-term results. Ann. Thorac. Surg. 2012; 94: 817-24.
27. Boucek M.M., Edwards L.B., Keck B.M., Trulock E.P., Taylor D.O., Mahacsi P.J. et al. Registry of the International Society for Heart and Lung Transplantation sixth official pediatric report-2003. J. Heart Lung Transplant. 2003; 22(6): 636-52.
28. Hertz M.I., Taylor D.O., Trulock E.P, Boucek M.M., Mohacsi P.J. et al. The registry of the International Society for Heart and Lung Transplantation: nineteenth official report- 2002. J. Heart Lung Transplant. 2002; 21(9): 950-70.
29. De Perrot M., Granton J.T. Qutcome of patients with pulmonary arterial hypertension refferred for lung transplantation: А 14-year single-center experience. J. Thorac. Cardiovasc. Surg. 2012; 143: 910-8.
30. Trulock E.P, Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., Hertz M.I. The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J. Heart Lung Transplant. 2004; 23(7): 804-15.
31. Rich S., Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am. J. Cardiol. 1983; 51(9): 1560-1.
32. Kerstein D., Levy P.S., Hsu D.T., Hordof A.J., Gersony W.M., Barst R.J. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation. 1995; 91: 2028-35.
33. Reichenberger F., Pepke-Zaba J., McNeil K., Parameshwar J.,
Shapiro L.M. Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax. 2003; 58:
797-800.
34. Vachiery J.L., Stoupel E., Boonstra A., Naeije R. Balloon atrial septostomy for pulmonary hypertension in the prostacyclin era. Am. J. Respir. Crit. Care. Med. 2003; 167: A692.
35. Micheletti A., Hislop A.A., Lammers A., Bonhoeffer P., Derrick G., Rees P., Haworth S.G. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart. 2006; 92(7): 969-72.
36. Law M.A., Grifka R.G., Mullins C.E., Nihill M.R. Atrial septostomy improves survival in select patients with pulmonary hypertension. Am. Heart J. 2007; 153: 779-84.
37. Sandoval J., Gaspar J., Pena H. et al. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur. Respir. J. 2011; 38 (6): 1343-8.
38. Sandoval J., Arroyo J.G., Gaspar J., Zamudio T.P. Interventional and surgical therapeutic strategies for pulmonary arterial hypertension: Beyond palliative treatments. J. Cardiol. 2015; 66: 304-4.
39. Lammers A.E., Derrick G., Haworth S.G., Bonhoeffer P, Yates R. Efficacy and long-term patency of fenestrated Amplatzer devices in children. Cathet. Cardiovasc. Interv. 2007; 70 (4): 578-84.
40. Stumper O., Gewillig M., Vettukattil J., Budts W., Chessa M., Chaudhari M., Wright J.G. Modified technique of stent fenestration of the atrial septum. Heart. 2003; 89(10): 1227-30.
41. FernsS.J., Wehrmacher W.H., Serratto M. Pediatric pulmonary arterial hypertension - a review. Comp. Ther. 2009; 35(2): 81-90.
42. Troost E., Delcroix M., Gewillig M. et al. A modified technique of stent fenestration of the interatrial septum improves patients with pulmonary hypertension. Cathet. Cardiovasc Interv. 2009; 73(2): 173-9.
43. Mertens L., Dumoulin M., Gewillig M. Effect of percutaneous fenestration of the atrial septum on protein-losing enteropathy after the Fontan operation. Br. Heart J. 1994; 72: 591-2.
44. Gewillig M., Mertens L., Stockx L. Percutaneous fenestration of the atrial septum with a stent: an experimental study. Cor Europaeum. 1995; 4: 122-5.
45. O’Laughlin M.P. Stent fenestration of hemi-Fontan baffles: an intriguing addition to the armamentarium. Cathet. Cardiovasc. Diagn. 1998; 43(4): 433.
46. Pedra C.A., Pihkala J., Benson L.N, Freedom R.M., Nykanen D. Stent implantation to create interatrial communications in patients with complex congenital heart disease. Cathet. Cardiovasc. Interv. 1999; 47(3): 310-3; discussion. 314.
47. Weimar T., Watanabe Y., Kazui T., Lee U.S., Montecalvo A., Schuessler R.B., Moon M. Impact of differential right-to-left shunting on systemic. Perfusion in pulmonary arterial hypertension division of cardiothoracic surgery, Washington University School of Medicine, Barnes-Jewish. Hospital, St. Louis, Missouri. Cathet. Cardiovasc. Interv. 2013; 81 (5): 888-95. Dd:10.1002/ccd.24458.
48. Alekyan B.G., Gorbachevsky S.V., Pursanov M.G., Grenade- rov M.A., Koltsov Y.A., Baryshnikova I.Y. et al. Stenting of the interatrial septum for the treatment of idiopathic pulmonary arterial hypertension. J. Invasive Cardiol. 2015 (in print).